Chicago IL 膀胱癌临床试验
21项针对 膀胱癌的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
招募中2 期
- Northwestern University, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
招募中2 期
- Rush MD Anderson Cancer Center, Chicago
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
招募中1 期
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- University of Illinois Cancer Center, Chicago
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- University of Chicago Hospital, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- 以及另外 1 项
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
招募中1/2 期
- University of Chicago Medical Center ( Site 5037), Chicago
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- The University of Chicago Medical Center (UCMC), Chicago
Measuring Surgical Recovery After Radical Cystectomy
招募中观察性研究
- University of Chicago, Chicago
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
招募中3 期
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
招募中3 期
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
招募中2 期
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
招募中2 期
- Northwestern University, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- The University of Chicago Comprehensive Cancer Center, Chicago
Blue Light Cystoscopy With Cysview® Registry
招募中观察性研究
- Northwestern University, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Chicago
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
招募中观察性研究
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
招募中
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
其他城市的 膀胱癌试验
- New York City, NY34 项研究
- Nashville, TN31 项研究
- Houston, TX31 项研究
- Dallas, TX27 项研究
- Washington, DC26 项研究
- Boston, MA26 项研究
- Los Angeles, CA24 项研究
- Baltimore, MD24 项研究
- St. Louis, MO22 项研究
- Edison, NJ22 项研究
- Philadelphia, PA21 项研究
- Seattle, WA21 项研究
Chicago的其他研究
- 非小细胞肺癌61 项研究
- 乳腺癌58 项研究
- 癌症（所有类型）52 项研究
- 转移性癌症45 项研究
- 前列腺癌45 项研究
- 肥胖症42 项研究
- 肺癌41 项研究
- 卵巢癌36 项研究
- 卒中34 项研究
- 心力衰竭32 项研究
- 结直肠癌32 项研究
- 超重28 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。